Heated humidified high-flow nasal cannula therapy in children.
Arch Dis Child
; 100(6): 571-5, 2015 Jun.
Article
en En
| MEDLINE
| ID: mdl-25452315
Heated humidified high-flow nasal cannula therapy (HHHFNC) was originally described as a mode of respiratory support in premature neonates and is now increasingly used in the management of acute respiratory failure in older infants and children. Heating and humidification of gas mixtures allow comfortable delivery of flow rates that match or exceed the patient's inspiratory flow rate. Emerging evidence from observational studies suggests that the use of HHHFNC therapy may be associated with reduced work of breathing, improved ventilation efficiency and a decreased need for intubation in children with respiratory insufficiency. There are several proposed mechanisms of action, and the potential for provision of unpredictable positive distending pressure has caused concern. Randomised controlled trial evidence comparing clinical outcomes with those achieved using other forms of respiratory support is, however, awaited. We review the proposed mechanisms of actions, indications, advantages and complications of HHHFNC therapy in children and describe our approach to its use in the paediatric ward environment.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Terapia por Inhalación de Oxígeno
/
Síndrome de Dificultad Respiratoria del Recién Nacido
/
Presión de las Vías Aéreas Positiva Contínua
/
Ventilación no Invasiva
Tipo de estudio:
Clinical_trials
/
Observational_studies
Límite:
Child
/
Humans
/
Infant
/
Newborn
Idioma:
En
Revista:
Arch Dis Child
Año:
2015
Tipo del documento:
Article
Pais de publicación:
Reino Unido